TB-500 is a synthetic peptide fragment associated with Thymosin Beta-4 (TB4), a naturally occurring protein involved in actin regulation and cell migration. It is commonly discussed in the context of recovery and tissue regeneration.

What does research suggest about TB-500?

Animal studies suggest Thymosin Beta-4 and related fragments may play roles in wound healing, angiogenesis, and cardiac tissue repair. However, robust human clinical trials of the research-market TB-500 fragment are lacking, so most findings are preclinical.

What are the reported side effects of TB-500?

Reported effects are largely anecdotal, with fatigue occasionally mentioned. Because rigorous human studies are lacking, the full side-effect and long-term safety profile remains unknown.

How does TB-500 compare to BPC-157?

Both are peptides frequently discussed together for recovery and tissue repair, and they are often compared in that context. Neither is an approved medicine, and human evidence for both remains limited and largely preclinical.

Is 'TB-500' the same thing as Thymosin Beta-4?

Not exactly, and this is a common point of confusion. Thymosin Beta-4 is a full naturally occurring protein of 43 amino acids. 'TB-500' is the name used on the research market for a synthetic fragment associated with that protein. Much of the science people cite refers to the full Thymosin Beta-4 studied in labs, not the research-market 'TB-500' material, which lacks robust human trials of its own. This is educational information, not medical advice.

Why is TB-500 so often mentioned together with BPC-157?

Both are discussed in the same recovery and regeneration conversations, so they are frequently compared or grouped as a pair. That pairing is a reflection of online discussion culture rather than of combined clinical evidence. Being talked about alongside a better-known peptide is not the same as having established human data, and neither is an approved medicine. This is general educational context only.

Why does TB-500 appear on anti-doping prohibited lists?

Thymosin Beta-4, referenced in sport contexts as 'TB-500', has been listed by anti-doping authorities among substances prohibited in competition. Inclusion on such a list reflects a regulatory and sporting-integrity decision, not an endorsement that the compound is safe, effective, or approved. Athletes subject to testing should be aware of its prohibited status. This is informational only and not guidance to use the compound.

Where can I buy TB-500 / Thymosin Beta-4 and compare vendors?

Use the vendor comparison on this page. It shows only checked, product-specific links and identifies vendor claims, independent documentation and affiliate relationships separately. Availability and legal status can vary by country.

Recovery / Regeneration

Buy TB-500 / Thymosin Beta-4 – Vendors, Prices, Testing and Evidence

Buy TB-500 / Thymosin Beta-4

Also known as: Thymosin Beta-4 · TB4

Evidence grade C — Early / PreclinicalRisk flag

Short answer

A peptide related to the naturally occurring protein Thymosin Beta-4, discussed for recovery and regeneration. Human evidence is limited.

Where can you buy TB-500 / Thymosin Beta-4?

Crystal Peptides. The table lists only product-specific offers that were checked and for which a real destination exists. Missing prices, quantities, stock and laboratory details are not inferred.

What is known?

TB-500 is a synthetic fragment associated with Thymosin Beta-4, a protein involved in cell migration and actin regulation.

What is not established?

Limited. Thymosin Beta-4 itself has been studied in some clinical contexts, but the research-market 'TB-500' fragment lacks robust human trials.

Safety

Human safety data is limited. Material sold on the research market is not quality-assured for human use.

Regulatory status

Not an approved medicine for general human use. Research chemical status in most jurisdictions.

Not medical advice. This educational reference is not diagnosis, treatment, prescribing, dosing or emergency guidance. Consult a qualified professional before making health-related decisions.

Regulatory or safety concern: This substance may be unapproved for human use, affect the hormonal system, or be subject to regulator or anti-doping restrictions. Check the cited evidence and rules in your jurisdiction.

Vendor comparison

Buy TB-500 / Thymosin Beta-4: compare vendors

The table lists only product-specific offers that were checked and for which a real destination exists. Missing prices, quantities, stock and laboratory details are not inferred.

Vendor	Product	Documentation	Shipping	Checked	Action
Crystal Peptides Code PEPTIDES10 −10% · discount code details Sponsored	TB-500 / Thymosin Beta-4 research product	Vendor-supplied data COA stated as available Not independently documented	Europe See the localized country store	Jul 18, 2026	View at vendor

Crystal Peptides

TB-500 / Thymosin Beta-4 research product

Code PEPTIDES10 −10% · discount code details

What is it?

TB-500 is a synthetic fragment associated with Thymosin Beta-4, a protein involved in cell migration and actin regulation.

Research and evidence

TB-500 is a synthetic peptide fragment associated with Thymosin Beta-4 (TB4), a naturally occurring protein found in most human cells that plays a role in regulating actin, a building block of the cytoskeleton. Because actin dynamics underpin cell migration, the parent protein has drawn interest in the study of wound healing, tissue repair, and regeneration. On the research market, "TB-500" typically refers to a short active fragment rather than the full-length Thymosin Beta-4 protein, and it is most often discussed in the context of recovery, connective-tissue repair, and comparisons with other repair-associated peptides such as BPC-157.

The reason TB-500 is researched comes from the biology of its parent protein. Thymosin Beta-4 has been investigated for proposed roles in angiogenesis (the formation of new blood vessels), cell migration to sites of injury, and modulation of inflammation and tissue remodelling. Animal studies have suggested involvement in wound healing and cardiac tissue repair, which is the source of much of the enthusiasm surrounding the peptide. It is important to keep the distinction clear: promising findings largely come from preclinical models and from work on Thymosin Beta-4 itself, not from rigorous human trials of the research-market "TB-500" fragment.

The honest evidence picture is limited. Human clinical data on TB-500 as sold on the research market is sparse, and the material available in that market is not quality-assured or manufactured for human use. TB-500 is not an approved medicine for general human use and holds research-chemical status in most jurisdictions; it is also a substance of interest to anti-doping authorities in sport. Reported effects are largely anecdotal, its long-term safety profile is not well characterised, and fatigue has been mentioned anecdotally by some who discuss it. TB-500 should be understood as an experimental research compound whose real-world benefits and risks in humans remain unproven, not as a validated treatment.

Evidence grade: C

Limited. Thymosin Beta-4 itself has been studied in some clinical contexts, but the research-market 'TB-500' fragment lacks robust human trials. Animal studies suggest roles in wound healing and cardiac tissue repair.

Human evidence

Limited. Thymosin Beta-4 itself has been studied in some clinical contexts, but the research-market 'TB-500' fragment lacks robust human trials.

Animal and preclinical evidence

Animal studies suggest roles in wound healing and cardiac tissue repair.

Proposed mechanisms

Proposed regulation of actin, supporting cell migration
Discussed roles in angiogenesis and tissue repair

Safety concerns and known side effects

Human safety data is limited. Material sold on the research market is not quality-assured for human use.

Fatigue reported anecdotally
Unknown long-term profile

Regulatory status

Not an approved medicine for general human use. Research chemical status in most jurisdictions.

TB-500 / Thymosin Beta-4 research timeline

Early 1980s
Thymosin Beta-4, a small naturally occurring protein, is isolated from thymus tissue and its amino-acid sequence described.
Early 1990s
Researchers characterize Thymosin Beta-4 as a major actin-sequestering molecule, clarifying its role in cell migration and the cytoskeleton.
2000s
Preclinical animal work explores Thymosin Beta-4 in wound healing, angiogenesis and cardiac tissue repair, generating much of the recovery-related interest.
2000s–2010s
The full Thymosin Beta-4 protein enters early-stage human clinical studies for indications such as dermal wounds and eye-surface conditions; results remain limited and it is not approved as a general medicine.
2010s
Anti-doping authorities list Thymosin Beta-4 (referencing 'TB-500') as a prohibited substance in sport, and the fragment spreads through the research-chemical market.
Early 2020s
Regulators issue broader cautions about unapproved injectable research peptides, while robust human trials of the research-market 'TB-500' fragment specifically remain absent.

Frequently asked questions about TB-500 / Thymosin Beta-4

What is TB-500?: TB-500 is a synthetic peptide fragment associated with Thymosin Beta-4 (TB4), a naturally occurring protein involved in actin regulation and cell migration. It is commonly discussed in the context of recovery and tissue regeneration.
What does research suggest about TB-500?: Animal studies suggest Thymosin Beta-4 and related fragments may play roles in wound healing, angiogenesis, and cardiac tissue repair. However, robust human clinical trials of the research-market TB-500 fragment are lacking, so most findings are preclinical.
Is TB-500 approved or legal?: TB-500 is not an approved medicine for general human use and holds research-chemical status in most jurisdictions. It is also prohibited in competitive sport under anti-doping rules.
Is TB-500 safe?: Human safety data is limited and its long-term profile is not well characterised. Material sold on the research market is not quality-assured or manufactured for human use, which adds further uncertainty about purity and risk.
What are the reported side effects of TB-500?: Reported effects are largely anecdotal, with fatigue occasionally mentioned. Because rigorous human studies are lacking, the full side-effect and long-term safety profile remains unknown.
How does TB-500 compare to BPC-157?: Both are peptides frequently discussed together for recovery and tissue repair, and they are often compared in that context. Neither is an approved medicine, and human evidence for both remains limited and largely preclinical.
Is 'TB-500' the same thing as Thymosin Beta-4?: Not exactly, and this is a common point of confusion. Thymosin Beta-4 is a full naturally occurring protein of 43 amino acids. 'TB-500' is the name used on the research market for a synthetic fragment associated with that protein. Much of the science people cite refers to the full Thymosin Beta-4 studied in labs, not the research-market 'TB-500' material, which lacks robust human trials of its own. This is educational information, not medical advice.
Why is TB-500 so often mentioned together with BPC-157?: Both are discussed in the same recovery and regeneration conversations, so they are frequently compared or grouped as a pair. That pairing is a reflection of online discussion culture rather than of combined clinical evidence. Being talked about alongside a better-known peptide is not the same as having established human data, and neither is an approved medicine. This is general educational context only.
Why does TB-500 appear on anti-doping prohibited lists?: Thymosin Beta-4, referenced in sport contexts as 'TB-500', has been listed by anti-doping authorities among substances prohibited in competition. Inclusion on such a list reflects a regulatory and sporting-integrity decision, not an endorsement that the compound is safe, effective, or approved. Athletes subject to testing should be aware of its prohibited status. This is informational only and not guidance to use the compound.
Where can I buy TB-500 / Thymosin Beta-4 and compare vendors?: Use the vendor comparison on this page. It shows only checked, product-specific links and identifies vendor claims, independent documentation and affiliate relationships separately. Availability and legal status can vary by country.

Common discussion areas

Recovery reportsComparison with BPC-157

Compare TB-500 / Thymosin Beta-4

TB-500 / Thymosin Beta-4 vs BPC-157

Sources

Thymosin Beta-4 and TB-500 in Tissue Healing, Regeneration, and Musculoskeletal Repair: A Scoping Review — Applied Sciences (MDPI)

Editorial review and transparency

Written by: peptides.cx Editorial Team
Scientific reviewer: No named medical reviewer is currently assigned
Last editorial review: June 1, 2026
Last vendor check: July 18, 2026
Review method: Source review, claim verification, vendor-data separation and regulatory-context review.
Commercial disclosure and conflicts: Vendor relationships do not determine evidence or safety ratings. No named reviewer conflict is recorded because no named reviewer is assigned.

Editorial policy →Evidence grade →Vendor methodology →

Related on peptides.cx

Library →Vendor quality checklist →Safety →Affiliate code: PEPTIDES10